We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

84 hedge funds and large institutions have $13.9M invested in Definium Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

905% more call options, than puts

Call options by funds: $9.99M | Put options by funds: $994K

11% more capital invested

Capital invested by funds: $12.6M → $13.9M (+$1.34M)

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.28% less ownership

Funds ownership: 10.36% → 10.08% (-0.28%)

5% less funds holding

Funds holding: 88 → 84 (-4)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

Holders
84
Holders Change
-4
Holders Change %
-4.55%
% of All Funds
1.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
13
Reduced
12
Closed
11
Calls
$9.99M
Puts
$994K
Net Calls
+$9M
Net Calls Change
+$217K

Top Buyers

1
CAM
Cresset Asset Management
Illinois
+$550K
2
BlackRock
BlackRock
New York
+$350K
3
CIC
Cornercap Investment Counsel
Georgia
+$195K
4
Group One Trading
Group One Trading
Illinois
+$173K
5
Millennium Management
Millennium Management
New York
+$161K

Top Sellers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$847K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$800K
3
Renaissance Technologies
Renaissance Technologies
New York
-$66.5K
4
Citadel Advisors
Citadel Advisors
Florida
-$51K
5
PCM
Prelude Capital Management
New York
-$39.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$2.85M -$847K -245,677 -24%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.03M -$20.9K -6,054 -1%
BlackRock
3
BlackRock
New York
$1.98M +$350K +101,320 +22%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.32M +$107K +30,955 +9%
BB
5
Busey Bank
Illinois
$872K – – –
Charles Schwab
6
Charles Schwab
California
$642K +$2.96K +859 +0.5%
CAM
7
Cresset Asset Management
Illinois
$569K +$550K +159,499 New
Two Sigma Investments
8
Two Sigma Investments
New York
$563K -$36K -10,441 -6%
State Street
9
State Street
Massachusetts
$436K – – –
DCI
10
Data Collective IV
California
$358K – – –
AI
11
AdvisorShares Investments
Maryland
$326K -$6.71K -1,946 -2%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$229K +$103K +29,782 +87%
Northern Trust
13
Northern Trust
Illinois
$221K +$12.6K +3,641 +6%
CIC
14
Cornercap Investment Counsel
Georgia
$202K +$195K +56,478 New
KPWS
15
Kestra Private Wealth Services
Texas
$183K – – –
Group One Trading
16
Group One Trading
Illinois
$179K +$173K +50,153 New
Millennium Management
17
Millennium Management
New York
$166K +$161K +46,553 New
Renaissance Technologies
18
Renaissance Technologies
New York
$130K -$66.5K -19,267 -35%
Morgan Stanley
19
Morgan Stanley
New York
$107K -$24.2K -7,008 -19%
LPL Financial
20
LPL Financial
California
$74.4K +$10 +3 +0%
Goldman Sachs
21
Goldman Sachs
New York
$56.5K – – –
FDCDDQ
22
Federation des caisses Desjardins du Quebec
Quebec, Canada
$50.4K – – –
Fidelity Investments
23
Fidelity Investments
Massachusetts
$44K +$42K +12,180 +8,230%
NSIM
24
North Star Investment Management
Illinois
$43K +$10.1K +2,925 +32%
FCH
25
Freestone Capital Holdings
Washington
$41K – – –
1
2 3 4

DFTX Hedge Fund Activity: Q2 2023 in Review

84 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2023, worth a combined $13.9M — up 11% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of DFTX and 8 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 13 added.

The largest buyer was Cresset Asset Management, opening a new position worth an estimated $550K. The largest seller was Alyeska Investment Group, cutting an estimated $847K.

  • 84 institutional investors held Definium Therapeutics (DFTX) as of Q2 2023, down from 88 in Q1 2023.
  • Funds reported $13.9M of Definium Therapeutics stock for Q2 2023, up 11% quarter-over-quarter.
  • 8 funds opened new Definium Therapeutics positions in Q2 2023 and 11 closed out, a net change of -3 holders.
  • The largest Definium Therapeutics buyer in Q2 2023 was Cresset Asset Management, an estimated $550K added.
  • The largest Definium Therapeutics seller in Q2 2023 was Alyeska Investment Group, an estimated $847K sold.

Based on aggregated 13F filings for Q2 2023.